日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ayurvedic Therapeutic Regimen as an Add-On to Optimized Conventional Management of Parkinson Disease: Protocol for an Exploratory Randomized Controlled Trial Evaluating Clinical, Cortical Excitability, Neuroimmune, and Autonomic Function Parameters

阿育吠陀疗法作为帕金森病优化常规治疗的辅助手段:一项探索性随机对照试验方案,旨在评估临床、皮质兴奋性、神经免疫和自主神经功能参数。

Chikkanna, Umesh; Pal, Pramod Kumar; Jameela, Sophia; Mahale, Rohan R; Kamble, Nitish; Shivakumar, Venkataram; Holla, Bharath; Yadav, Ravi; Holla, Vikram V; Sathyaprabha, Talakad Narasappa; Udupa, Kaviraja; Sahoo, Srinibash; Venkataswamy, Manjunath M; Ganapathy, Selva; Rao, Chandra Shekara; Yadav, Babita; M, Sreenithya; Varambally, Shivarama; Bhat, Sulochana; Srikanth, Narayanam; Ramakrishna, Kishore Kumar

Comprehensive screening of potential inhibitors from ZINC15 database for Metallo-L1 Β -Lactamase from Stenotrophomonas maltophilia via in Silico and in vitro approaches

利用计算机模拟和体外方法,对 ZINC15 数据库中嗜麦芽窄食单胞菌 Metallo-L1 β-内酰胺酶的潜在抑制剂进行全面筛选。

Sreenithya, K H; Manoharadas, Salim; Sugumar, Shobana

Protein-protein interaction network study of metallo-beta-lactamase-L1 present in Stenotrophomonas maltophilia and identification of potential drug targets

对嗜麦芽窄食单胞菌中存在的金属β-内酰胺酶L1进行蛋白质-蛋白质相互作用网络研究,并鉴定潜在药物靶点

Sreenithya, K H; Sugumar, Shobana

Identification of natural inhibitor against L1 β-lactamase present in Stenotrophomonas maltophilia

鉴定嗜麦芽窄食单胞菌中存在的L1 β-内酰胺酶天然抑制剂

H, Sreenithya K; Jade, Dhananjay; Harrison, Michael A; Sugumar, Shobana

Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury

微粒作为高糖诱发肾细胞损伤的潜在介质

Sreenithya Ravindran, Mazhar Pasha, Abdelali Agouni, Shankar Munusamy

Structure-activity relationship of piperine and its synthetic amide analogs for therapeutic potential to prevent experimentally induced ER stress in vitro

胡椒碱及其合成酰胺类似物的结构-活性关系及其在体外预防实验诱发的内质网应激的治疗潜力

Ayat S Hammad, Sreenithya Ravindran, Ashraf Khalil, Shankar Munusamy